Promising Drug Trial , Appears to Cure , Cancer Patients.<br />'The Independent' reports that an experimental cancer <br />drug used in a small clinical trial in the United States <br />appears to have cured all patients involved.<br />The 12 rectal cancer patients were given <br />dostarlimab over a six-month period. .<br />According to a study published <br />in the 'New England Journal of Medicine,' <br />all 12 patients' cancer went into remission.<br />This is the first time this has <br />happened in the history of cancer, Dr Luis Diaz, Study lead author and oncologist <br />at the Memorial Sloan Kettering Cancer Center (MSKCC), <br />via 'The New York Times'.<br />According to the study, patients experienced <br />no significant negative side effects <br />while receiving the treatment.<br />However, 'The Independent' points out that the small trial did not involve enough people to highlight the potential adverse reactions caused by the drug.<br />Dostarlimab is an immunotherapy drug <br />used to treat endometrial cancer.<br />This was the first trial to see whether <br />the drug would also be effective <br />against rectal cancer tumors.<br />'The Independent' reports that the drug works by tagging cancer cells and allowing the immune system to identify and destroy them.<br />According to the study, all patients <br />appear to still be cancer free two years <br />after receiving the treatment.<br />None of the patients went on to receive chemotherapy or undergo surgery.
